Table 2.
Numbers of skin-test-positivity depending on type of tests and clinical manifestations (%); [95%CI]
| immediate reading positivea (n) | late reading positiveb (n) | |
|---|---|---|
| Anaphylactic manifestationsc n = 45 | n = 17 (37.8%), [25.1%–52.4%] | n = 0 (0%), [0%–7.9%] |
| Delayed DHR-manifestationd n = 106 | n = 1 (0.9%), [0.05%–5.2%] | n = 25 (23.6%), [16.5 %-32.5%] |
| Unclassifiable/othere n = 24 | n = 0 (0%), [0%–13.8%] | n = 1 (4.2%), [0.2%–20.2%] |
IDT with immediate reading and/or prick test.
IDT with late reading and/or patch test.
including cases with bronchospasm, acute urticaria/angioedema.
Macular/maculopapular exanthema, pustular exanthema, bullous exanthema, DRESS, SDRIFE, FDE.
including delayed urticaria/angioedema